ethyl-N6-(benzyloxycarbonyl)-2,6-diaminopurin-9-yl-acetate | 202343-70-2

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: ethyl-N6-(benzyloxycarbonyl)-2,6-diaminopurin-9-yl-acetate
• 英文别名: Ethyl 2-[2-amino-6-(phenylmethoxycarbonylamino)purin-9-yl]acetate
• CAS: 202343-70-2
• 化学式: C₁₇H₁₈N₆O₄
• 分子量: 370.368
• InChiKey: SFQWDJUXSRVVGH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  27
• 可旋转键数：
  8
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.24
• 拓扑面积：
  134
• 氢给体数：
  2
• 氢受体数：
  8

反应信息

• 作为反应物：
  描述：

  ethyl-N6-(benzyloxycarbonyl)-2,6-diaminopurin-9-yl-acetate 以 sodium hydroxide 为溶剂， 以2.82 g (98%)的产率得到2-amino-6-(benzyloxycarbonylamino)purin-9-ylacetic acid
  参考文献：
  名称：

  Peptide nucleic acids having 2,6-diaminopurine nucleobases

  摘要：

  一种新型化合物类别，被称为肽核酸，比相应的DNA链和RNA链结合更牢固，并表现出增强的序列特异性和结合亲和力。该发明的肽核酸包括从天然存在的核碱基和连接到聚酰胺骨架的非天然核碱基中选择的配体。该发明的一些肽核酸还包含C1-C8烷基胺侧链。

  公开号：

  US06414112B1

文献信息

• SEQUENCE SPECIFIC DOUBLE-STRANDED DNA/RNA BINDING COMPOUNDS AND USES THEREOF
  申请人：RAYAN ANWAR

  公开号：US20100284959A1

  公开（公告）日：2010-11-11

  The present invention provides specific double-stranded DNA/RNA binding compounds having a polymeric structure, which are in fact, triplex forming molecules capable of binding tightly and specifically to predetermined sequences in the major groove of double stranded nucleic acid molecules; as well as pharmaceutical compositions comprising thereof. The triplex forming molecules and the pharmaceutical compositions of the invention can be used for various therapeutic applications such as site-specific modulation of gene expression and targeting of DNA or RNA damage, as well as for diagnostic applications in vitro.

  本发明提供了具有聚合结构的特定双链DNA / RNA结合化合物，实际上是三链形成分子，能够紧密而特异地结合到双链核酸分子的主沟槽中的预定序列；以及包括它们的制药组合物。本发明的三链形成分子和制药组合物可用于各种治疗应用，例如位点特异性基因表达调节和DNA或RNA损伤的靶向，以及体外诊断应用。
• [EN] SEQUENCE SPECIFIC DOUBLE-STRANDED DNA/RNA BINDING COMPOUNDS AND USES THEREOF<br/>[FR] COMPOSÉS DE LIAISON À L'ADN/ARN DOUBLE BRIN SPÉCIFIQUES DE CERTAINES SÉQUENCES ET LEURS UTILISATIONS
  申请人：GENEARREST LTD

  公开号：WO2012011114A2

  公开（公告）日：2012-01-26

  The present invention provides specific double-stranded DNA/RNA binding compounds having a polymeric structure, which are in fact, triplex forming molecules capable of binding tightly and specifically to predetermined sequences in the major groove of double stranded nucleic acid molecules; as well as pharmaceutical compositions comprising thereof. The triplex forming molecules and the pharmaceutical compositions of the invention can be used for various therapeutic applications such as site-specific modulation of gene expression, targeting of DNA or RNA damage, and gene knockout, as well as for diagnostic applications in vitro.
• Peptide nucleic acids having 2,6-diaminopurine nucleobases
  申请人：——

  公开号：US06414112B1

  公开（公告）日：2002-07-02

  A novel class of compounds, known as peptide nucleic acids, bind complementary DNA and RNA strands more strongly than a corresponding DNA strand, and exhibit increased sequence specificity and binding affinity. The peptide nucleic acids of the invention comprise ligands selected from a group consisting of naturally-occurring nucleobases and non-naturally-occurring nucleobases attached to a polyamide backbone. Some PNAs of the invention also contain C1-C8 alkylamine side chains.

  一种新型化合物类别，被称为肽核酸，比相应的DNA链和RNA链结合更牢固，并表现出增强的序列特异性和结合亲和力。该发明的肽核酸包括从天然存在的核碱基和连接到聚酰胺骨架的非天然核碱基中选择的配体。该发明的一些肽核酸还包含C1-C8烷基胺侧链。